Editorial: WHO Needs Funding, Not Scapegoating (Seattle Times, Quotes Judd Walson

Congress must quickly reverse President Donald Trump’s defunding of the World Health Organization.

This should be a bipartisan priority, to provide U.S. leadership in combating the worldwide pandemic and support WHO’s broader, ongoing global-health mission.

The WHO made errors in its initial response to the coronavirus but so did Trump, who is scapegoating and undermining a critical health organization when it’s desperately needed to save lives.

Africa Needs Afrocentric Solutions to Beat COVID-19 (Seattle Times - Written by Kingsley Ndoh)

While the U.S. and Europe battle to slow the spread of the novel coronavirus, I can’t help but think about how Africa will cope when it becomes the next epicenter. Based on the three-month-old data that we have about the virus and its spread, guidelines on prevention, containment and mitigation have been set by the World Health Organization (WHO). So far, several African governments have adopted the U.S. and European approach that is centered on lockdowns, social distancing and frequent hand washing with soap and water.

Senior Community Protected in 'Outbreak that Didn’t Happen' (Study led by Alison Roxby)

Newly reported research findings may help in detecting and preventing the spread of COVID19 at independent and assisted living community for senior adults.

One of the valuable lessons from the study at an affected retirement center in Seattle:  Health-professionals should not rely solely on symptoms to determine if an older adult should receive a lab test for the coronavirus.

Now is the Time for a National Public Health Reserve (The Hill - Co-Authored by Alison Drake)

Even before the COVID-19 pandemic, health departments had limited staff, resources and time to support the diverse public health needs of our communities. This system will be further strained as the epidemic grows. We must immediately create a national public health reserve to shore up public health systems. 

First Vaccine Trial for SARS-CoV-2 (includes Rhea Coler)

The Coler Lab at Seattle Children’s Research Institute is using their expertise to support the clinical trial of an experimental coronavirus vaccine funded by National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health. The trial is being conducted at the Kaiser Permanente Washington Health Research Institute in Seattle, part of NIAID’s Infectious Diseases Clinical Research Consortium.

Study Shows Link Between COVID-19 and Heart Issues, Poor Outcomes for Patients on Ventilators (UW School of Public Health - Study led by Matt Arentz)

A University of Washington study provides some of the first details of 21 critically ill patients with the coronavirus disease 2019 (COVID-19) in the United States, most of whom were linked to exposures at a nursing home at the center of the country’s COVID-19 outbreak early on in the global crisis.

Pages